Daniel Cantillon

Dr. Cantillon is Senior Vice President of Global Cardiovascular Solutions at Masimo, a medical device technology company specializing in non-invasive monitoring solutions based in Irvine, CA. He is former Cleveland Clinic where he served as Associate Section Head & Research Director of Cardiac Electrophysiology and Pacing, and Medical Director of the Central Monitoring Unit (CMU), which provided continuous remote patient monitoring to Cleveland Clinic’s main campus and 10 regional hospitals with a capacity of over 2,000 monitored beds. His work earned distinction as Cleveland Clinic’s Innovator of the Year for Health Information Technology and later the prestigious Sones-Favaloro award for innovation. Dr. Cantillon’s notable first-in-human achievements include implant of the world’s first entirely leadless pacemaker – subcutaneous defibrillator system, and the first dual chamber leadless pacemaker in the United States. His notable research achievements include original publications in the New England Journal of Medicine and Journal of the American Medical Association.

Honoraria/Speaking/Consulting Fee: Boston Scientific, Abbott
Royalty Income: AirStrip Inc.